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ABSTRACT 
In  the  previous study,  lymphocyte surface  molecules were  separated  into  two 
subsets  depending  on  whether  capping  was  associated  with  redistribution  of 
cytoplasmic  myosin.  In  the  present  study,  the  effects of the  local  anesthetic 
chlorpromazine  and of the Ca  2+ ionophore A23187 were compared. Both drugs 
affected the surface redistribution of immunoglobulin (Ig), Fc receptors, and the 
TL antigen-molecules that  appear to cap by association with microfilaments- 
but had no effect on the Thy.1  (0) and H2 antigens-molecules that cap slowly, 
apparently  unlinked  to microfilament function. The capping of Ig,  Fc receptor, 
and TL was inhibited while that of H2 and 0 was not. Both drugs reversed the Ig, 
Fc receptor,  and TL caps but not the H2 and 0 caps. In the former group, the 
reversal of caps was accompanied by a parallel reversal of the myosin segregated 
to the cap area. The appearance of myosin after drug treatment varied: chlorpro- 
mazine  resulted  in  a  diffuse  pattern  similar  to  that  of  normal  lymphocytes, 
whereas  A23187  produced  an  array  of aggregates  and  coarse  filaments.  The 
results are compatible with the view that two mechanisms for capping exist in the 
lymphocyte. The Ca  2+ ionophore may affect capping of microfilamentodependent 
caps by producing a systemic activation of contractile proteins while chlorproma- 
zine may act by disrupting a CaZ+-dependent link between surface complexes and 
the contractile proteins. 
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The evidence presented in the accompanying pa- 
per (1) suggested that lymphocyte membrane mol- 
ecules fall into two distinct classes with respect to 
their spontaneous or ligand-induced redistribution 
into  polar  caps.  Antibodies to  immunoglobulin 
(Ig), antibodies to thymic leukemia antigen (TL), 
and immune complexes which bind to Fc receptors 
all form caps associated with  a  concentration of 
myosin in the underlying cytoplasm. On the other 
hand,  antibodies  against  the  histocompatibility 
antigen  (H2)  or  to  theta  antigen  (0)  form  caps 
without associated cytoplasmic myosin. To gather 
further  information  about  the  mechanisms  of 
these  surface  molecule  redistributions,  we  now 
have  studied  the  effects  of the  Ca  2+  ionophore 
A23187  and the local anesthetic chlorpromazine 
on  the  capping of the  various surface  molecules 
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419 and the distribution  of cytoplasmic myosin.  Both 
drugs  were  known  to  inhibit  Ig  capping  and  to 
disrupt  previously  formed  Ig  caps  (2-5).  Given 
circumstantial  evidence  that  Ca  2§  entry  during 
ionophore  treatment  might  cause  a  generalized, 
disorganized cortical contraction  (4)  and that  the 
anesthetic might disrupt links between contractile 
proteins  and  the  plasma  membrane  (2,  5),  we 
predicted that the drugs might perturb the capping 
of only those molecules which depend on contrac- 
tile proteins. Such a differential effect of the drugs 
was  found,  providing  further  evidence  for  two 
distinct capping mechanisms in the lymphocyte. In 
passing,  we  also  have  evaluated  the  effects  of 
sodium  azide,  a  metabolic  inhibitor  known  to 
inhibit capping (7), on the distribution of cytoplas- 
mic myosin. 
MATERIALS AND  METHODS 
Preparation of cells and antisera and methods for study- 
ing  capping  were  identical  to  those  reported  in  the 
accompanying paper  (1).  The only new reagent was  a 
goat anti-rabbit  IgG. This was  an  IgG fraction conju- 
gated to fluorescein at a  molar ratio of 8.4,  used at a 
concentration of 290/zg/ml. In one experimental proto- 
col (that of Fig. 6), we utilized an unlabeled rabbit anti- 
mouse Ig. This was from the same batch as the fluores- 
cein-conjugated reagent described before (1). 
Drugs 
Chlorpromazine  (Smith,  Kline, and  French  Labora- 
tories,  Philadelphia,  Pa.)  and  sodium  azide  (Fisher 
Chemical  Company,  Fair  Lawn,  N.  J.)  were  freshly 
prepared in 0.15 M phosphate-buffered saline, pH 7.2. 
A23187 was a gift from Eli Lilly Company, Indianapolis, 
Ind. It was dissolved in dimethyl sulfoxide (DMSO) at 1 
mg/ml and  stored  at  4~  Serial dilutions of A23187 
were made in medium immediately before use.  Corre- 
sponding  dilutions  of  DMSO  alone  had  no  effect on 
capping. 
Experimental Protocols 
Two experimental protocols were used: one tested the 
effect of drugs  on  cap  formation;  another  tested  the 
effect of drugs on caps  which had  already formed. To 
study  the influence of the drug on cap formation, cells 
were  incubated  on  ice  with  antisera,  rinsed  in  cold 
medium, and aliquoted at 5  ￿  106 cells/0.5-ml medium 
in  individual  tubes.  The cells were then settled for 30 
min  on  ice  with  appropriate  drug  dilutions  and  then 
incubated under conditions, described in the accompa- 
nying paper, which allowed optimal capping. 
For Ig-a  fluoreseein-conjugated anti-Ig,  25  rain  at 
20~  Fc receptor- an immune complex of hemocyanin- 
antihemocyanin,  10  min  at  37~  TL-with  anti-TL 
serum, 10 min at 37~  the anti-TL was then detected in 
fixed cells by the use of fluorescent anti-Ig. 0 and H2- 
with appropriate antisera followed by incubation with a 
fluorescent anti-Ig, 30 rain at 37~ 
To study  the influence of the drugs on formed caps, 
cells were exposed to antisera, rinsed, and aliquoted into 
tubes as described above but were settled in the absence 
of drugs.  The cells were then incubated at the appropri- 
ate temperature and time interval, allowing normal cap 
formation. When the capping interval ended, drugs were 
added;  the  cells  were  further  incubated  (10  min with 
A23187; 20 min with other drugs)  and finally fixed with 
paraformaldehyde. 
In both cases,  the cells were rinsed twice in medium 
after fixation, resuspended in fetal calf serum, smeared 
on cover slips,  and air dried. The cover slips were then 
stained with rhodamine ant/myosin  and examined with a 
Leitz Ortholux II microscope using  fluorescent epiiUu- 
ruination.  The appropriate excitation and barrier filters 
were used to detect in the same cell the surface com- 
plexes tagged with the fluorescein label and the myosin 
labeled with the rhodamine-conjugated antibody. Cells 
were considered capped  when the fluorescent reaction 
covered less  than  half the  cell  surface.  At  least  200 
stained  cells  were scored for each experimental point. 
Except for the experiments with anti-TL and  anti-H2, 
which  were done only once, the remaining studies  re- 
ported here were done at least on three different occa- 
sions with identical results. 
RESULTS 
Effects of Chlorpromazine and A23187 
on Myosin Distribution  in 
Untreated L ymphocytes 
Chlorpromazine  had  no  effect  on  the  diffuse 
antimyosin  staining  of the  lymphocyte cytoplasm 
(at  10-4-10 -5  M)  (Fig.  1,  panels  A  and  B). 
A23187  at 0.01-0.1  /~g/ml in medium containing 
Ca  2+ caused  the antimyosin  staining to  aggregate 
into  coarse,  irregular  clumps.  In  most  cells  the 
antimyosin  clumps  formed  a  network  of  coarse 
bands,  sometimes centering on one point (Fig.  1, 
panels  C  and  D).  The  effects  of the  ionophore 
were  not  observed  in Ca2+-depleted  medium.  In 
cells treated  with ionophore  in regular Ca2+-con  - 
taining medium  and then fixed, subsequent  reac- 
tion  with  ligands  revealed  that  -10%  of  the 
surface Ig and Fc receptors were redistributed into 
coarse  patches,  most  of  which  appeared  to  be 
closely associated  with  the  myosin  aggregates  in 
the cytoplasm (Fig. 2, panel A). Patching of 0 was 
not observed in T  cells treated with A23187.  (H2 
and TL were not tested.) 
420  THE  JOURNAL OF  CELL BIOLOGY' VOLUME 79, 1978 FIGURE 1  Fluorescence micrographs of splenic lymphocytes stained  with rhodamine antimyosin for 
cytoplasmic myosin. Treatments (A) none; (B) 10  -4 M chlorpromazine for 30 min at 37~  (C and D) 
0.1/zg/ml A23187 for 10 min at 37~  Note the coarse filamentous pattern produced by A23187 in some 
cells (arrowhead). Similar patterns were observed on lymphocytes treated  with ligands before or after 
addition of the drugs. 
FICURE 2  Fluorescence micrographs of splenic lymphocytes stained with (left) fluorescein anti-Ig for 
surface Ig and (right) with rhodamine antimyosin for cytoplasmic mosin. (A) splenic lymphocytes were 
exposed to A23187 (0.1 /~g/ml)  for 30 min, then fixed and stained. (B) splenic lymphocytes were bound 
with anti-Ig at 0~176  rinsed, and incubated at 37~  in the presence of sodium azide (10 mM). After 30 
min, the cells were fixed to terminate the reaction and stained with antimyosin. Note the correspondence 
of many surface Ig patches with myosin aggregates. 
Effects of Chlorpromazine or A23187 
on the Capping o  fig, Fc Receptors, and 
TL and on the Redistribution of 
Cytoplasmic Myosin 
Chiorpromazine  inhibited in  a  concentration- 
dependent fashion the capping of Ig, Fc receptors, 
and  TL  and  the  redistribution  of  cytoplasmic 
myosin  which  usually  takes  place  when  these 
molecules cap. The antimyosin staining remained 
diffuse  as  in Fig.  1,  panel B.  The  inhibition of 
anti-Ig capping was 70-75%  at  10 -s M  and 90- 
100%  at  10 -4  M  (see  also  reference  3  and the 
experiment of  Fig.  7,  described  later).  Fig.  3, 
upper left panel, shows the results with Fc recep- 
tors.  In a  single experiment, capping of TL was 
inhibited by 95% at 10 -4 M chlorpromazine. 
A23187  also  inhibited the  capping of  Ig,  Fc 
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FIGURE  3  Effects  of chlorpromazine and A23187  on 
immune complex cap formation and disruption. Splenic 
lymphocytes were exposed to immune complexes at 0  ~ 
4~  rinsed, and incubated at 37~  to promote capping. 
(Top) incubation in the presence of various concentra- 
tions of chlorpromazine or A23187. After  10 min, the 
reaction was terminated with paraformaldehyde, and the 
cells were stained with antimyosin to compare the effect 
of these drugs on cap formation and myosin segregation. 
(Bottom) after cap formation, various concentrations of 
chlorpromazine or A23187 were added to the lympho- 
cytes, and incubation was continued for an additional 20 
or  10 min, respectively. The reaction was then termi- 
nated with paraformaldehyde, and the cells were stained 
with antimyosin to compare the effect of these drugs on 
formed caps and myosin segregation. 0---0, Fc Recep- 
tor; ￿9169  myosin. 
receptors, and TL and the cytoplasmic redistribu- 
tion of myosin. The inhibition of Ig capping was 
well detailed before (4) and was confirmed now 
using concentrations of 0.01-0.1  /xg/ml.  The ef- 
fects  on Fc receptor capping are shown in Fig. 3, 
upper right panel. In the single experiment done, 
capping of TL was inhibited by 90% at a dose of 
0.1  /xg/ml.  All  these  effects  of  the  ionophore 
required Ca  2§ in the medium. The distribution of 
myosin was as depicted in Fig. 1, panel C and D, 
in coarse aggregates. 
Parallel Disruption o  fig, Fc Receptors, 
and TL Caps by Chlorpromazine 
and A23187 
Chlorpromazine dispersed the  formed caps of 
Ig, immune complexes, and TL and their under- 
lying concentrations of antimyosin staining mate- 
rial. With chlorpromazine, the capped complexes 
redistributed into a  random, finely granular pat- 
tern. The antimyosin staining pattern was diffuse, 
as in Fig. 1 B. 
Treatment with A23187 in CaZ+-containing  me- 
dium caused both the capped complexes and the 
cytoplasmic antimyosin staining material to reor- 
ganize into coarse, irregular patches (Fig. 1, C and 
D). Figs. 3 and 4 show the results of Fc receptor 
and  Ig  cap  disruption. Table  I  summarizes the 
effects of A23187 on Ig capping. 
Effects of Chlorpromazine or A23187 
on Cap Formation and Cap Disruption 
of O  and H2 
Chlorpromazine slightly enhanced, rather than 
inhibited, the capping of anti-0 (Fig. 5). A23187 
had  little  effect  except  at  high  concentrations. 
Neither drug disrupted previously formed 0 caps. 
Similar results were  obtained in a  single experi- 
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FIGURE 4  Disruption  of  Ig  caps by  chlorpromazine 
and A23187. Splenic lymphocytes  were exposed to anti- 
Ig at 0~176  rinsed, and incubated at 25~  to induce 
capping. After 25 rain, chlorpromazine or A23187 was 
added at various concentrations, and the incubation was 
continued for an additional 20 or 10 min, respectively. 
The  reaction was then  terminated with paraformalde- 
hyde, and the cells were stained with antimyosin. O---II, 
surface Ig; 0--0, myosin. 
% 
I 
O'O.OOt 00t  0.t  0.5 
422  THE  JOURNAL  OF  CELL  BIOLOGY ￿9 VOLUME  79,  1978 TABLE  I 
Summary ofA23187 Effects on the Distribution of Surface lg and Myosin 
Experimental manipulation  Distribution of surface Ig  Distribution of myosin 
Fix --~ Anti-Ig  Diffuse 
Anti-lg-~ 37~  Fix  Caps  in  more  than 
90% of cells 
A23187 ~  Fix--~ Anti-Ig  Patches  in  10%  of 
cells 
A23187 --~ Anti-Ig --~ 37~  --* Fix  Capping  inhibited; 
patches 
Anti-Ig -~ 37~  --* A23187 ~  Fix  Caps  disrupted; 
patches 
Diffuse 
Segregated to the area of the cap in more 
than 50% of cells 
Random aggregates and coarse filaments 
in all cells 
Polar  segregation  inhibited;  random  ag- 
gregates and coarse filaments 
Polar  segregation  inhibited;  random  ag- 
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Effect of chlorpromazine and A23187 on 0 
caps.  Thymocytes were  exposed  sequentially to  anti-0 
and anti-Ig at 0~  as described in Materials and Meth- 
ods, and incubated at 37~  to induce capping. (Top) cap 
formation  was  examined  in  the  presence  of  various 
concentrations of chlorpromazine or A23187. After 30 
rain,  the  reaction  was  terminated  with  paraformalde- 
hyde.  (Bottom) cap formation was induced  in the  ab- 
sence  of  drugs.  After  a  30-min  incubation,  various 
concentrations  of  chloropromazine  or  A23187  were 
added to the capped cells, and incubation was continued 
for an additional 20 or 10 min, respectively. The reaction 
was terminated with paraformaldehyde. 
Effects of Sodium Azide on Ig, 
H2, and 0 Capping 
The  metabolic  inhibitor  sodium  azide  had  no 
influence  on  the  distribution  of  myosin  in  un- 
treated  lymphocytes  but  inhibited  both  the  cap- 
FIGURE 6  Patches  of H2.  T  cells with patches of H2 
(A) show diffuse  staining  of myosin (B). The plane of 
the  photograph  of myosin  is  focused  on  the  edge  to 
demonstrate the lack of patching of myosin, which was 
diffuse. 
ping of Ig and  altered  the  redistribution  of cyto- 
plasmic  myosin  which  usually  accompanies  cap- 
ping. In the presence of azide (10 mM), the anti- 
Ig formed patches on the outside of the cells, and 
the  myosin  formed  aggregates  in  the  cytoplasm, 
but  azide  prevented  a  subsequent  step  in  which 
both  types  of molecules become  concentrated  at 
one  pole  to  form  a  cap.  In  many  instances,  the 
surface patches  of Ig appeared  to be close to the 
cytoplasmic myosin aggregates  (Fig.  2,  panel B). 
T  cells treated  with either anti-H2  or anti-0  (and 
anti-Ig)  in  the presence  of azide did not cap and 
had a diffuse distribution of myosin (Fig. 6). 
Effects of Chlorpromazine on Anti-Ig 
Capping Induced by Two Ligands 
The capping of 0  and  Ig seem to be fundamen- 
tally  different  (Table  II)  but,  in  the  presence  of 
chlorpromazine,  Ig could be induced to cap much 
like  0;  the  rate  was  slow,  two  ligands  were  re- 
quired (rabbit antimouse Ig plus a goat anti-rabbit 
Ig), and there was no redistribution of cytoplasmic 
myosin (Figs.  7  and  8).  Specifically, if B  lympho- 
cytes  were  incubated  in  the  cold  with  unlabeled 
BRAUN ET  AL.  Redistribution  of Lymphocyte Surface Macromolecules H  423 TABLE  II 
Redistribution of Two Sets of Surface Molecules 
Ligand-induced  capping 
Myosin 
Number of li-  segrega-  Spontaneous  cap- 
Molecule  Cells  Rate  gands  tion  Motility  A23187  Local anesthetic  ping 
% 
Ig  80-100  Fast  One  Yes  Stimulated  Prevents  or  Prevents  or  breaks  Yes: to uropod 
breaks caps  caps 
Fc recep-  80-100  Fast  One  Yes  Stimulated  Prevents  or  Prevents  or  breaks  Yes: to uropod 
tars  breaks caps  caps 
TL  90  Fast  One  Yes  Stimulated  Prevents  or  Prevents  or  breaks  Yes 
breaks caps  caps 
Con A  40-50  Interme-  One-very  _+  -  Not done  Not done  No 
diate  dose  de- 
pendent 
O  30-50  Slow  Two  No  No effect  No effect  Slight  enhancement;  No:  partial  exclu- 
no disruption  sion  from  uro- 
pod 
H2  30-50  Slow  Two  No  No effect  No effect  Slight  enhancement;  No:  partial  exclu- 
no disruption  sion  from  uro- 
pod 
100 
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FIGURE 7  Capping of  Tg by two ligands  in  the presence 
of chlorpromazine. Splenic lymphocytes  were exposed at 
0~  to  unconjugated rabbit  anti-lg or  sequentially to 
anti-Ig and to fluorescein-conjugated  goat anti-rabbit Ig 
rabbit anti-mouse Ig followed by fluorescein goat 
anti-rabbit Ig and then at 37~  in the presence of 
chlorpromazine, the Ig capped but slowly without 
redistribution of cytoplasmic myosin. 
Formation of caps  under these  conditions re- 
quired an  appropriate  concentration of the  first 
antibody and of chlorpromazine. The best results 
were obtained with cells exposed to 100/~g/ml of 
antimouse Ig  (50%  capping); with  50  /zg,  only 
12%  capped; and with  10  /xg, less  than 5%, all 
after  being treated  with  100  ~g/ml  of the  anti- 
rabbit IgG. 
DISCUSSION 
Although the  cellular mechanisms of action are 
not entirely known, chlorpromazine and A23187 
have been extraordinarily valuable in our analysis 
of capping because, they have allowed us to iden- 
tify two subsets of lymphocyte surface molecules 
with different capping properties (Table II). The 
(anti-antibody). The cells were rinsed and incubated at 
37~  in the presence of chlorpromazine for the periods 
of time indicated. The reactions were terminated with 
paraformaldehyde, and surface Ig was visualized  on cells 
exposed to  anti-Ig alone by staining with fluorescein- 
conjugated goat anti-rabbit Ig after fixation. Cells ex- 
posed  to  anti-Ig  alone:  Ik--@,  no  chlorpromazine; 
I--I,  10  -5 M chlorpromazine; A--A, 10  -4 M chlor- 
promazine. Cells exposed sequentially to anti-Ig and to 
anti-antibody: A--A, 10  -4 M chlorpromazine. In the 
absence of chlorpromazine, the kinetics of capping were 
identical in cells treated with anti-Ig alone or with both 
anti-Ig and anti-antibody. 
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receptors,  and  TL  were  striking: cap  formation 
was  inhibited;  formed  caps  were  disrupted.  In 
marked contrast, 0  and  H2  cap formation were 
not  inhibited,  even  slightly  enhanced;  and  cap 
disruption was minimal or absent. At face value, 
these results imply that the mechanism subserving 
capping  of  each  group  of  molecules  must  be 
different. The molecules with drug-sensitive cap- 
ping are all thought to cap actively, accompanied 
by  a  redistribution  of  cytoplasmic myosin.  The 
molecules  with  drug-insensitive  capping  cap 
slowly, independent of a direct association and/or 
activation of microfilaments by a progressive for- 
mation of large membrane aggregates. Our inter- 
pretation of the mechanisms of these two forms of 
capping was discussed in the accompanying paper. 
To  summarize  the  effects  of  chlorpromazine 
found  in  this  and  previous  studies:  (a)  it  stops 
capping  or  disrupts  formed  caps  of those  mole- 
cules that  are  associated with cytoplasmic segre- 
gation of myosin  (Figs. 3  and  4);  (b)  it has  no 
effect or even enhances slightly capping of mole- 
cules  not  associated  with  myosin  redistribution 
(Fig. 4);  and  (c)  when  it disperses caps,  it also 
disperses the cytoplasmic myosin segregated with 
the  cap (Fig. 3);  (d)  it disrupts caps even in the 
presence of inhibitors of energy metabolism (5); 
and (e) its effects on capping are antagonized by 
high concentrations of extracellular Ca  2§  (5). All 
five  of  these  properties  are  compatible  with  a 
mechanism in which the drug (which is known to 
interact with  membrane  lipids  [6])  in  some way 
severs the link between surface complexes and the 
contractile  apparatus  of the  cell, most  likely by 
displacement of membrane-bound Ca  2+. Once this 
putative link is broken, the complexes are free to 
diffuse  within  the  plane  of  the  membrane.  In 
accordance,  molecules that  cap  without  associa- 
tion  with  contractile  elements  (like  0  and  H2) 
would not be expected to be affected in a negative 
way by the anesthetic, which is the case. Rather, 
because these anesthetics can increase membrane 
fluidity, it  is  interesting  to  note  that  the  latter 
molecules are slightly enhanced in their extent of 
capping. Lastly, although Ig capping was inhibited 
by chlorpromazine, it was possible to induce it in 
the presence of the drug if large aggregates were 
formed on the  membrane  (by using an antibody 
to  anti-Ig).  Under  these  conditions,  Ig  capping 
was slow and was not associated with segregation 
of  myosin,  as  took  place  under  usual  circum- 
stances  (experiment  of Fig.  7).  Thus,  Ig  in  the 
presence of chlorpromazine had the same capping 
characteristics  as  0.  Our  interpretation  of  the 
effects of tertiary amine anesthetics is compatible 
with that offered by Poste et al.,  which suggested 
that  the  drugs  displace microfilaments from  the 
cell surface (2). 
The Ca  2§ ionophore, in turn: (a) also stops cap 
formation or breaks caps of molecules associated 
with myosin segregation, but  (b)  does not affect 
molecules that do not segregate myosin; (c) pro- 
duces  a  redistribution  of  myosin  into  a  coarse 
network;  and  (d)  its  effects  on  cap  disruption 
require energy metabolism (4). These effects are 
compatible  with  the  explanation  that  the  Ca  2§ 
influx produced by the ionophore interferes with 
the  organized process of activation of contractile 
proteins required for formation and maintenance 
of the cap. 
This  and  the  accompanying study  (1)  support 
the contention that two forms of capping exist in 
the lymphocyte. When the capping properties of 
lymphocyte surface molecules are compared (Ta- 
ble  II),  two  patterns  emerge:  in  one  case,  the 
contractile  apparatus  intimately  and  selectively 
interacts  with  certain  surface  molecules;  in  the 
other case, the role of the contractile apparatus, if 
any, is indirect. Thus, the molecular basis of these 
forms of capping may differ fundamentally. The 
pharmacological approach used here  in conjunc- 
tion with biochemical studies should provide fur- 
ther  understanding  of  the  different  mechanisms 
FIGURE 8  Fluorescence  micrograph of B lymphocytes with Ig caps in the presence of chlorpromazine. 
Splenic lymphocytes  were  exposed sequentially  at 0~176  to anti-Ig and anti-antibody.  The cells were 
rinsed, incubated  at 37~  for 30 min in the presence  of 10  -4 M chlorpromazine,  then fixed and stained 
with antimyosin. (A) fluorescein fluorescence of surface Ig; (B) rhodamine antimyosin. Note the absence 
of myosin segregation beneath the surface Ig caps. 
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